📈 Markets Jump After Supreme Court Overrules Trump’s Tariffs

Plus Superinvestors Sell Nvidia, Buy Meta and more...

TOP STORY
📈 Markets Jump After Supreme Court Overrules Trump’s Tariffs

😰 Since last April, when Trump announced a wave of tariffs on ‘Liberation Day’, the markets have swung up and down with every new tariff announcement as uncertainty swept through the market.

🧑‍⚖️ Back in June, a three-judge panel actually ruled the tariffs ‘illegal’, but Trump vowed to fight this ruling to the Supreme Court.

😮 Well, this week, the Supreme Court made its decision, striking down the tariffs in a 6-3 ruling.

🟢 This gave the market a small boost, as investors hope the ruling should mean fewer tariff surprises moving forward:

  • The S&P 500 rose 1.07%

  • The Nasdaq 100 rose 1.13%

  • The TSX rose 2.25%

But while the market only jumped ~1%, stocks that have been hit hard by the tariffs jumped a lot:

  • Lululemon ($LULU) jumped 6.8% this week (still down over 50% since Liberation Day)

  • Amazon ($AMZN) ended the week up 4.7%, Apple up 2.5%

  • European stocks rose to all-time highs, with stocks like Hermes jumping 3.6%

👊 But celebrations were short-lived as Trump vowed to find other channels to impose tariffs, and the markets digested the massive headache of tariff refunds. So let’s break down what happened, and what this all means for the markets moving forward…

🚧 Trump Vows to Fight, Saying He Has “Backup Plans” on Tariffs

🤔 Ok, first of all - how can the President’s tariffs be ruled illegal? Isn’t he the President?

⚠️ Well, the ruling was really about the way Trump imposed tariffs, which were under the emergency law, saying that annual trade deficits were “an unusual and extraordinary threat” to national security and the economy.

⚖️ The Supreme Court disagreed, saying that as per the U.S. Constitution, the decision to levy tariffs on another country had to be approved by Congress.

👎 Trump was quick to respond, saying he was “absolutely ashamed” of some of the justices who ruled against the tariffs, adding:

“Their decision is incorrect. But it doesn’t matter because we have very powerful alternatives.”

President Trump

⚡ And Trump didn’t wait around. Within hours of the ruling, Trump signed an order imposing a flat 10% tariff on all imports under Section 122 of the Trade Act of 1974, effective February 24, then raising it to 15% within a day.

🛡️ He also announced broader use of Section 232 (tariffs under national security) and Section 301 (tariffs for unfair trade practices) statutes, two laws giving him the ability to impose tariffs outside of the IEEPA (the emergency act that the Supreme Court ruled unlawful for tariffs).

💬 U.S. Treasury Secretary Bessent made it clear that “this administration will invoke alternative legal authorities to replace the IEEPA tariffs” and said that these alternatives would result in virtually unchanged tariff revenue for 2026.

😰 The Uncertainty Continues

📈 📉 So while the ruling was significant, its impact on the market was pretty short-lived. Stocks like Nike jumped 4% on Friday morning, but then ended the day down -1.3% as the market digested Trump’s response.

⁉️ While the ruling should limit the speed and severity of Trump’s ability to set tariffs, it opens the door for new questions, like what happens to the $133B in tariffs that have already been collected?

💰 Many companies, like Costco and Walmart, have already lined up in court to demand refunds, but there is likely a long legal battle ahead. Trump made it clear that the US government will not make immediate refunds despite the ruling, since the Supreme Court did not explicitly state that the administration needs to make refunds, saying the matter could “end up in court for the next 5 years”.

💡 All in all, this ruling does matter, but there’s still a long road ahead. Dan Siluk, a portfolio manager at Janus Henderson, put it best by saying:

“The decision underscores a shift toward slower, more procedurally constrained trade policy, reducing headline volatility.”

Dan Siluk, Janus Henderson, Head of Global Short Duration & Liquidity

🔮 In other words, the era of tariff announcements moving markets by 3% overnight is probably over. But tariffs themselves aren’t.

🤿 In other news this week, the Superinvestors (like Warren Buffett, Bill Ackman, and Masayoshi Son) filed their ‘13Fs’, giving us insight into what they’re buying and selling. So let’s take a look at the most significant moves this quarter…

SPONSORED BY FIDELITY INVESTMENTS CANADA
🎂 Celebrating five years of FBAL & FGRO!

🎊 Five years is a big milestone for any ETF. It can act as that sweet-spot indicator for how that investment performs. 

🎁 Two members of the Fidelity All‑in‑One ETF family just hit their five-year milestone, and we’re excited to celebrate!

🎯 Since 2021, FBAL and FGRO have been helping investors simplify their portfolios’ diversification strategy with a mix of equities, fixed income and a sprinkle of crypto.

⚖️ With automatic rebalancing baked right in, they’ve helped make portfolio management feel like a piece of cake.

⭐️ Join the celebration and see how FBAL and FGRO could sweeten your portfolio!

*See Fidelity Investments Canada Disclaimer at the end of the newsletter

SUPERINVESTOR MOVES
👨‍💼 Bill Ackman Bets Big on Meta, Buffett Buys New York Times, and more…

📊 In other news, the Q4 2025 13F filings are in. And in celebration of super investor trades officially coming to Blossom, it’s time we take a look at the smartest portfolios on Wall Street and what story they’re telling.

👇 Here are the Top 3 moves that stood out most this quarter:

🛍️ Bill Ackman Bets Big On Meta and Buys More Amazon

💡 The most significant moves this week were from Bill Ackman, the billionaire hedge fund manager behind the $15B+ hedge fund Pershing Square Capital.

🤖 Amid all the AI jitters, Bill Ackman took a bold new stake in Meta, bringing it up to ~12% of his portfolio and saying:

Meta has a “deeply discounted valuation” and that he believes “concerns around Meta’s AI-related spending initiatives are underestimating the company’s long-term upside potential from AI.”

Bill Ackman

📈 At the same time, Ackman raised his Amazon exposure by 65%, doubling down on his AI bets, with Mag 7 stocks now nearly 40% of his entire portfolio.

💼 To fund the moves, he exited the last of his Chipotle position and sold about ¼ of his total Google position, but despite the sale, Google remains Pershing’s third-largest holding.

🥳 P.S. You can now see Ackman’s full portfolio and trades on Blossom with the latest update this week!

🗞️ Buffett Buys 3% of the New York Times

👀 Another Superinvestor everyone watches each 13F closely is Warren Buffett, aka Berkshire Hathaway. And while we say ‘Buffett’, Berkshire is now run by Greg Abel (the new CEO) after Buffett stepped down, though Buffett still oversees the company as Chairman.

🆕 While Berkshire’s moves were relatively light this quarter, one interesting one was the purchase of more than 5 million shares of The New York Times ($NYT). While for Buffett this is <0.2% of his total portfolio, it amounts to 3% of the entire New York Times, underscoring how challenging it is for Berkshire to build up positions that meaningfully swing the portfolio.

✂️ Berkshire also sold more than 75% of its Amazon ($AMZN) position (although this was <1% of the portfolio before) and continued its long-running trims of both Apple ($AAPL) and Bank of America ($BAC).

🥳 P.S. You can now see Buffett’s full portfolio and trades on Blossom with the latest update this week!

🤖 Masayoshi Son Goes All-In on OpenAI, Sells Nvidia

👀 Last but not least, Masayoshi Son, the founder of Softbank, who arguably had the most singificant move this quarter.

This quarter, Softbank completely sold out of its Nvidia ($NVDA) stake for $5.8 billion, the second time Son has exited the AI giant.

The reason? To prepare for more investment into OpenAI.

🧠 SoftBank currently owns about an 11% stake in OpenAI after investing more than $30 billion last year, and the company plans to invest as much as $30 billion more this year in a round that would value the startup at about $800 billion.

🗣️ According to SoftBank’s CFO Yoshimitsu Goto the sale has “nothing to do with Nvidia itself,” but was needed to fund the OpenAI efforts.

🔄 However, with swirling concerns about OpenAI’s ability to make it’s obligations and the fears of ‘circular deals’ propping up the AI industry, it’s very interesting to see a big player have to dump one AI giant to buy another… and with increasing competition to OpenAI from Gemini, Claude, Anthropic and more, the move respresents a big bet on a single player in the ecosystem.

🥳 P.S. You can now see Son’s full portfolio and trades on Blossom with the latest update this week!

Alright, before our final story of the week (a highlight of the TSX Venture 50 list featuring 50 companies that hit an average +431% share price appreciation this year), a quick word from our other sponsor this year Harvest ETFs…

SPONSORED BY HARVEST ETFS
🏥 Position Your Portfolio for Healthcare’s Comeback

🩺 Healthcare remains an essential, diversified, and innovation-led sector.

⭐️ The Harvest Healthcare Leaders Income ETF (TSX: HHL), Canada’s largest listed healthcare ETF, captures this exposure through twenty large-cap healthcare equities. HHL recently won the FundGrade A+ Award 2025.

Benefits of HHL in 2026:

🌎 Global healthcare exposure for Canadian investors

HHL delivers access to twenty, large-cap healthcare equities from global leaders like Eli Lilly, Stryker, and others.

🗓️ Access to long-term secular drivers in healthcare

Healthcare’s long-term trajectory is underpinned by long-term drivers like aging populations, spending in developing countries, and technological innovations.

📉 Healthcare valuations have reached a 30-year low

Valuations in the healthcare space remain in attractive territory relative to the broader market in early 2026.

🎯 Consistent, growing income for 10+ years

HHL has never missed a monthly distribution payout since its inception and recently increased its monthly payout to $0.06 per unit

*See Harvest ETFs Disclaimer at the end of the newsletter

CANADIAN TOP PERFORMERS
🚀 The TSX Venture50 List is Live, Showcasing 50 Stocks With Average +431% Returns

🏆 The TSX just released its annual Venture 50 list, a ranking of the 50 top-performing companies on the TSX Venture Exchange over the past year, scored equally on share price appreciation, market cap growth, and trading volume… and some of the numbers were truly eye-dropping…

📊 In 2026, the 50 companies on this list posted an average price performance of 431%, generating over $17 billion in new market cap. To highlight a few:

  • Santacruz Silver Mining ($SCZ), a Latin America–focused silver producer, ranked #1 with an incredible +1103% share price growth

  • Ucore Rare Metals ($UCU), a North American critical-minerals company focused on advancing secure rare earth refining, ranked #2 with +627% share price growth

  • Millennial Potash ($MLP), a development-stage potash company with direct access to fertilizer markets in Brazil, the United States, and Africa, ranked #3 with +950% share price growth.

⛏️ Interestingly, mining accounted for 48 of the top 50 performers, marking what the President of the TSX Venture Exchange describes as a clear inflection point for the market:

“The list showcases a historic year for junior mining and high-tech innovation, reflecting an increase in global investor demand and market confidence in the Canadian capital markets at a time when resource security, critical technologies, and domestic supply chains have become strategic priorities worldwide.”

🌼 Blossom is an official media partner of the TSX Venture 50 this year, so if you want to dig into the full list and add some of these stocks to your watchlist, be sure to check the “Markets” tab on the app (mobile-only) or check out the list here on the TSX website!

FROM THE BLOSSOM COMMUNITY
⭐️ Top Discussions of the Week

👇 Click to see the full post!

Fidelity Investments Canada Disclaimer

Source: Fidelity Investments Canada ULC, as at January 31, 2026; ticker symbol FBAL and FGRO.

Returns shown in Canadian dollars, net of fees.

Commissions, trailing commissions, management fees, brokerage fees and expenses may be associated with investments in mutual funds and ETFs. Please read the mutual fund or ETF’s prospectus, which contains detailed investment information, before investing. The indicated rates of return are historical annual compounded total returns for the period indicated including changes in unit value and reinvestment of distributions. The indicated rates of return do not take into account sales, redemption, distribution or option charges or income taxes payable by any unitholder that would have reduced returns. Mutual funds and ETFs are not guaranteed. Their values change frequently, and investors may experience a gain or a loss. Past performance may not be repeated.

Each of the Fidelity All-in-One ETFs (excluding Fidelity All-in-One Fixed Income ETF) has a neutral mix which includes a small allocation to Fidelity Advantage Bitcoin ETF™ ranging between 0.5% and 3%. Additionally, if the portfolio deviates from its neutral mix by greater than 5% between annual rebalances, the portfolio will also be rebalanced. In the case of a Fidelity All-in-One ETF’s allocation to cryptocurrency, if the portfolio weight exceeds twice its neutral weight, the allocation will be brought back to its neutral weight, with any proceeds being reallocated to the other underlying Fidelity ETFs at their approximate strategic allocations. Such rebalancing activity may not occur immediately upon crossing that threshold but will occur shortly thereafter. 

The ETF/ETF Funds are subadvised by Geode Capital Management, LLC. 

© 2026 Fidelity Investments Canada ULC. All rights reserved. Fidelity Investments is a registered trademark of Fidelity Investments Canada ULC

Harvest ETFs Disclaimer

Commissions, management fees and expenses all may be associated with investing in Harvest Exchange Traded Funds managed by Harvest Portfolios Group Inc. (the “Funds”). Please read the relevant prospectus before investing. The indicated rates of return are the historical annual compounded total returns (except for figures of one year or less, which are simple total returns) including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. The Funds are not guaranteed, their values change frequently, and past performance may not be repeated. Distributions are paid to you in cash unless you request, pursuant to your participation in a distribution reinvestment plan, that they be reinvested into available Class units of the Fund you own. If a Fund earns less than the amounts distributed, the difference is a return of capital.

FundGrade A+® is used with permission from Fundata Canada Inc., all rights reserved. It reflects risk-adjusted performance and is based on Fundata’s GPA-style 12-month methodology with assigned grades A to E and corresponding scores 4 to 0. Funds with a GPA of 3.5+ receive a FundGrade A+®. There are 21 ETFs in the Health Care Equity category (CIFSC). For full methodology, visit www.FundGradeAwards.com.